Publications by authors named "Ruixin Ge"

Claim this Profile
A
Author Correction: Identification of a non-inhibitory aptameric ligand to CRL2 E3 ligase for targeted protein degradation.
Zhihao Yang, Miao Chen, Ruixin Ge, Ping Zhou, Wei Pan

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates.
Yan Li, Jian Song, Ruixin Ge, Xiangrui Luo, Ping Zhou

Eur J Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities.
Rui-Xin Ge, Miao Chen, Qing-Chao Li, Min Liu, Jun Zhou

Acta Pharmacol Sin· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation.
Yanran Li, Kaiwen Bao, Jiyue Sun, Ruixin Ge, Qiqing Zhang

Nat Struct Mol Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA nanoflower Oligo-PROTAC for targeted degradation of FUS to treat neurodegenerative diseases.
Ruixin Ge, Miao Chen, Sijin Wu, Sirui Huang, Ping Zhou

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a non-inhibitory aptameric ligand to CRL2 E3 ligase for targeted protein degradation.
Zhihao Yang, Miao Chen, Ruixin Ge, Ping Zhou, Wei Pan

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted degradation of membrane and extracellular proteins with LYTACs.
Yu-Yang Li, Yang Yang, Ren-Shuai Zhang, Rui-Xin Ge, Song-Bo Xie

Acta Pharmacol Sin· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Degradation of HCV Polymerase by GalNAc-Conjugated ApTACs for Pan-Genotypic Antiviral Therapy with High Resistance Barriers.
Wei Pan, Sijin Wu, Honglin Zhou, Yaodong Xia, Qingchao Li, Ruixin Ge

J Med Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYLD/HDAC6 signaling regulates the interplay between epithelial-mesenchymal transition and ciliary homeostasis during pulmonary fibrosis.
Hua Ni, Miao Chen, Dan Dong, Yunqiang Zhou, Yu Cao, Ruixin Ge

Cell Death Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer.
Lingping Kong, Fanlu Meng, Ping Zhou, Ruixin Ge, Xiaoshan Geng

Sci Bull (Beijing)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective degradation of the p53-R175H oncogenic hotspot mutant by an RNA aptamer-based PROTAC.
Lingping Kong, Fanlu Meng, Sijin Wu, Ping Zhou, Ruixin Ge

Clin Transl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoskeletal networks in primary cilia: Current knowledge and perspectives.
Ruixin Ge, Minghui Cao, Miao Chen, Min Liu, Songbo Xie

J Cell Physiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC6 regulates antibody-dependent intracellular neutralization of viruses via deacetylation of TRIM21.
Songbo Xie, Linlin Zhang, Dan Dong, Ruixin Ge, Qianqian He

J Biol Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis